Home > Income Statement > WINDLAS BIOTECH

WINDLAS BIOTECH
Consolidated Net Profit

    Back to Income Statement
WINDLAS BIOTECH is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹58 Cr₹43 Cr₹38 Cr₹16 Cr₹16 Cr

What is the latest Consolidated Net Profit of WINDLAS BIOTECH ?

The latest Consolidated Net Profit ratio of WINDLAS BIOTECH is ₹58 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹58 Cr
Mar2023₹43 Cr
Mar2022₹38 Cr
Mar2021₹16 Cr
Mar2020₹16 Cr

How is Consolidated Net Profit of WINDLAS BIOTECH Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹58 Cr
36.51
Mar2023 ₹43 Cr
11.91
Mar2022 ₹38 Cr
140.58
Mar2021 ₹16 Cr
-2.35
Mar2020 ₹16 Cr -

Compare Consolidated Net Profit of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹2,057.1 Cr -0.9% -5.9% 76.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,314.0 Cr -0.4% 5.7% 20.2% Stock Analytics
DIVIS LABORATORIES ₹162,809.0 Cr 1.7% 6.2% 52.9% Stock Analytics
CIPLA ₹124,627.0 Cr -0.7% 7% 8.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹111,127.0 Cr -1.6% 1.5% 21.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,839.9 Cr -2.3% 2.5% -6% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-0.9%

-5.9%

76.5%

SENSEX

2%

4.1%

9.6%


You may also like the below Video Courses